These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1037152)

  • 1. Plasma factor XIII and platelet factor XIII in hyperlipaemia.
    Cucuianu MP; Miloszewski K; Porutiu D; Losowsky MS
    Thromb Haemost; 1976 Dec; 36(3):542-50. PubMed ID: 1037152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor XIII in human plasma and platelets.
    McDonagh J; McDonagh RP; Delâge JM; Wagner RH
    J Clin Invest; 1969 May; 48(5):940-6. PubMed ID: 5780202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation factor XIII concentration in sickle-cell disease.
    Ittyerah R; Alkjaersig N; Fletcher A; Chaplin H
    J Lab Clin Med; 1976 Oct; 88(4):546-54. PubMed ID: 965808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XIII and its substrates, fibronectin, fibrinogen, and alpha 2-antiplasmin, in plasma and urine of patients with nephrosis.
    Vaziri ND; Gonzales E; Barton CH; Chen HT; Nguyen Q; Arquilla M
    J Lab Clin Med; 1991 Feb; 117(2):152-6. PubMed ID: 1993857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet and plasma Factor 13 (fibrin-stabilizing factor).
    Kiesselbach TH; Wagner RH
    Thromb Diath Haemorrh Suppl; 1967; 26():155-65. PubMed ID: 4965104
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical studies concerning factor XIII; with special reference to hyperlipemia.
    Cuculanu MP; Vasile VV; Popescu TA; Opincaru A; Crîsnic I; Tapalagå D
    Thromb Diath Haemorrh; 1973 Dec; 30(3):480-93. PubMed ID: 4787669
    [No Abstract]   [Full Text] [Related]  

  • 7. Distribution of fibrinogen, and platelet factors 4 and XIII in subcellular fractions of human platelets.
    Broekman MJ; Handin RI; Cohen P
    Br J Haematol; 1975 Sep; 31(1):51-5. PubMed ID: 1212435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proceedings: Determination of Factor XIII (fibrin-stabilizing factor) in plasma and blood platelets].
    Ballerini G; Franceschini F; Guerra S; Meduri P; Scagliarini F
    Quad Sclavo Diagn; 1973 Mar; 9(1):497-581. PubMed ID: 4210088
    [No Abstract]   [Full Text] [Related]  

  • 9. [Change in factor XIII activity in plasma during thrombocyte aggregation].
    Pastorova VE; Umarova BA
    Biull Eksp Biol Med; 1975 Jul; 80(7):14-7. PubMed ID: 1227639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease.
    Tacke F; Fiedler K; von Depka M; Luedde T; Hecker H; Manns MP; Ganser A; Trautwein C
    Liver Int; 2006 Mar; 26(2):173-81. PubMed ID: 16448455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation factor XIII, endothelial damage and systemic sclerosis.
    Marzano AV; Federici AB; Gasparini G; Mannucci PM; Caputo R; Berti E
    Eur J Dermatol; 2000; 10(1):14-7. PubMed ID: 10694291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microtiter assay for measurement of factor XIII activity in plasma.
    Dempfle CE; Harenberg J; Hochreuter K; Heene DL
    J Lab Clin Med; 1992 May; 119(5):522-8. PubMed ID: 1349910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes of factor XIII a and b subunit in patients with disseminated intravascular coagulation syndrome].
    Sugimura D; Fukue H; Arai M; Matsumoto K; Fukutake K
    Rinsho Byori; 1996 Apr; 44(4):355-61. PubMed ID: 8847818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XIII (fibrin-stabilizing factor) and platelets. I. Study of the association of factor XIII with blood platelets.
    Rolović Z
    Acta Med Iugosl; 1968; 22(1):113-23. PubMed ID: 5735663
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma fibronectin and factor XIII in nephrotic syndrome.
    Rus HG; Cucuianu M; Manasia M; Spînu C; Cristea A; Nanulescu M
    Med Interne; 1987; 25(2):105-11. PubMed ID: 3112925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma transglutaminase activity in congenital total and partial factor XIII deficiency (a contribution to the problem of factor XIII determination)].
    Egbring R; Andrassy K; Egli H
    Thromb Diath Haemorrh; 1971; 25(1):166-77. PubMed ID: 5577969
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduction of coagulation factor XIII concentration in patients with myocardial infarction, cerebral infarction, and other thromboembolic disorders.
    Alkjaersig N; Fletcher AP; Lewis M; Ittyerah R
    Thromb Haemost; 1977 Dec; 38(4):863-73. PubMed ID: 579691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation.
    Gödje O; Gallmeier U; Schelian M; Grünewald M; Mair H
    Thorac Cardiovasc Surg; 2006 Feb; 54(1):26-33. PubMed ID: 16485185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor XIII levels in five families of patients with inherited factor XIII deficiency: support for an autosomal recessive inheritance.
    Fear JD; Miloszewski KJ; Losowsky MS
    Thromb Haemost; 1983 Aug; 50(2):588-90. PubMed ID: 6636036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.